MDS Pharma Services

MDS Pharma Services, one of three business units that make up MDS Inc., is a leading global contract research organization that provides early stage drug-discovery and development services to pharmaceutical and biotech companies around the world. It is headquartered in King of Prussia, U.S., near Philadelphia, and has operations in six countries. MDS Pharma Services competes in a market worth an estimated US$5 billion.

MDS Pharma Services delivers Quality On Time™ services to help clients bring new drugs to market by applying scientific expertise to the early stage drug discovery and development process.

Identifying promising leads for new drugs.

Ruling out unpromising leads early in the process.

Conducting clinical research to test the safety and effectiveness of new drugs.

Navigating the drug regulatory environment.

MDS Pharma Services continues to strengthen its global presence, most recently with major expansions of its Phase I clinic in Phoenix, U.S. MDS Pharma Services will continue to consider strategic investments to strengthen and expand its business to meet the growing needs of clients.
Learn more.

FACTS

MDS Pharma Services has invested in new information technologies to better serve clients, including the next-generation ClinQuick® study-management system in early clinical research.

In 2008, MDS Pharma Services won two Good Clinical Practice Journal awards for excellence in clinical research for data-management and project-management services, which enabled the contract research organization to further demonstrate its Quality On Time™ brand promise.

In 2008, the performance of MDS Pharma Services was tracked against client expectations. The contract research organization has achieved a 95% on-time report delivery for its locations that conduct bioanalysis, and a 99% on-time report delivery for locations that provide drug safety assessment services.